title: A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients.
authors.forename: M
authors.initials: M
authors.lastname: Fava
authors.forename: K
authors.initials: K
authors.lastname: Johe
authors.forename: L
authors.initials: L
authors.lastname: Ereshefsky
authors.forename: L G
authors.initials: LG
authors.lastname: Gertsik
authors.forename: B A
authors.initials: BA
authors.lastname: English
authors.forename: J A
authors.initials: JA
authors.lastname: Bilello
authors.forename: L M
authors.initials: LM
authors.lastname: Thurmond
authors.forename: J
authors.initials: J
authors.lastname: Johnstone
authors.forename: B C
authors.initials: BC
authors.lastname: Dickerson
authors.forename: N
authors.initials: N
authors.lastname: Makris
authors.forename: B B
authors.initials: BB
authors.lastname: Hoeppner
authors.forename: M
authors.initials: M
authors.lastname: Flynn
authors.forename: D
authors.initials: D
authors.lastname: Mischoulon
authors.forename: G
authors.initials: G
authors.lastname: Kinrys
authors.forename: M P
authors.initials: MP
authors.lastname: Freeman